Northpond Ventures leads Series C round for Ultivue

Cambridge, Massachusetts-based Ultivue, a provider of tissue biomarker identification and quantification assays for translational and pathology research labs, has secured $22 million in Series C funding. Northpond Ventures led the round with participation from other investors that included ARCH Venture Partners, 6 Dimensions Capital, Yonghua Capital and Applied Ventures.